ReviewBlood research2023

Management of adverse events in young adults and children with acute B-cell lymphoblastic leukemia receiving anti-CD19 chimeric antigen receptor (CAR) T-cell therapy.

Jae Won YooPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.